CVR 36995149Entrepreneurial company (IVS)Uoplyst (999999)VirumFounded 13 Aug 2015
CVR holds no employment figures for this company.
Compiled by Dandex from the Central Business Register (CVR, datacvr.virk.dk), Erhvervsstyrelsen, and annual reports filed in XBRL. Values marked Dandex estimate are computed by Dandex from that data, not registered.
Dandex is Danish company data. Connect it once and ask about Opio IVS, or any Danish company, from your assistant, the API or the command line. Answers come from the current record: owners and the ownership network, financials year by year, and the latest registered changes.
Set Up DandexRevenue
532.4K
DKK, annual report 2016
Result
+37.6K
DKK, annual report 2016
Equity
37.6K
DKK, annual report 2016
Bruun Kolbye Holding IVSCVR 36993073, 100% of capital and votes, until 10 May 2020
Thomas Bruun Kolbyeuntil 29 Aug 2018
No current owner is registered.
Holders of 5% or more, from the owner register. CVR records shares in bands, not exact figures.
CVR 36993073100% of capital and votes13 Aug 2015 to 10 May 2020
Decided by Dandex with fixed rules from the CVR register and the filed annual reports, not registered by the company. Each label links to its definition.
CVR lists no current officers for this company.
CVR records founders at incorporation. It does not record whether they are alive or still involved.
13 Aug 2015 to 11 Nov 2026.
| Metric | 2016 |
|---|---|
| Revenue | 532 |
| Operating profit | +48 |
| Result for the year | +38 |
| Equity | 38 |
| Total assets | 353 |
| Credit metrics (Dandex calculations) | |
| EBIT margin (overskudsgrad) | 9% |
| EBITDA / gross profit (EBITDA i procent af bruttofortjenesten) | Pro: in the Pro plan, see pricingEBITDA as a share of gross profit. |
| Net interest-bearing debt (NIBD, nettorentebærende gæld) | Pro: in the Pro plan, see pricingInterest-bearing debt less cash and current securities; negative is net cash. |
| Gearing, NIBD / EBITDA | Pro: in the Pro plan, see pricingNet interest-bearing debt over EBITDA: the years of earnings the debt takes. |
| Interest coverage (rentedækning) | Pro: in the Pro plan, see pricingEBIT over finance expenses: how many times earnings cover the interest. |
| Adjusted equity ratio (justeret soliditetsgrad) | Pro: in the Pro plan, see pricingAdjusted equity as a share of total assets on the same basis. |
| ROIC (afkast af investeret kapital) | Pro: in the Pro plan, see pricingReturn on invested capital: EBIT after tax over equity plus net debt. |
| Capex % of sales (investeringer i procent af omsætningen) | Pro: in the Pro plan, see pricingCapex as a share of revenue. |
| FCFF / EBITDA (pengestrømskonvertering) | Pro: in the Pro plan, see pricingFree cash flow to the firm as a share of EBITDA. |
DKK thousands. Annual reports via XBRL. 2016 covers 17 months (13 Aug 2015 to 31 Dec 2016).
Credit metrics are Dandex calculations from the filed figures, not filed values; estimates are in grey with a note. Ratios are percentages. Gearing and interest coverage are multiples. Rows marked Pro hold a value in the Pro plan. Definitions.
Dandex has recorded no changes to this company since it began following the register.
Pro: in the Pro plan, see pricingChanges worth a look, raised from the registry and new annual reports.
New leadership (Nyt lederskab), New company (Ny virksomhed), Ownership change (Ejerskifte), Relocation (Flytning), Growth surge (Vækstspurt), Headcount decline (Nedgang i ansatte), Restructuring (Omstrukturering), Industry change (Brancheskift), Board change (Bestyrelsesændring), Dissolution (Ophør), Distress warning (Risikoadvarsel), Fund investment (Fondsinvestering), Fund exit (Fondsexit), Fund board seat (Fondsbestyrelsespost).
The rows marked Pro on this page hold values in the Pro plan. For Opio IVS, that is:
Have Pro? Sign in to see the values on this page.
Each registered value from the day it took effect, newest first.
From CVR, read 11 Nov 2026. Text such as the signing rule and purpose is shown as registered.
5 registrations, newest first. As published by Erhvervsstyrelsen, in Danish, with people's street addresses cut to postcode and city.
Konkursbehandlingen afsluttet 25.05.2020, virksomheden opløst
Konkursdekret afsagt 20.09.2019 af Sø- og Handelsrettens Skifteretsafdeling
Likvidatorer:
Fratrådte:
Michael Christian Torben Serring, den 20.09.2019.
Revision:
Likvidatorer:
Tiltrådte:
Sø- og Handelsrettens Skifteretsafdeling har udnævnt følgende likvidatorer: Michael Christian Torben Serring, 2100 København Ø, den 16.07.2019.
Virksomheden tegnes af en likvidator.
Virksomhedens kreditorer opfordres til at anmelde deres krav til likvidator. Krav skal anmeldes senest tre måneder fra dags dato.
Anmodning om opløsning, jf. selskabslovens § 225 sendt til Sø- og Handelsrettens Skifteretsafdeling den 29.08.2018
Direktion:
Fratrådte:
Thomas Bruun Kolbye, den 29.08.2018.
CVR-nummer:
36995149.
NAVN:
Opio IVS.
Adresse: Virum Overdrevsvej 43, 2830 Virum.
Kommune: Lyngby-Taarbæk.
Stiftelsesdato: 13.08.2015.
Seneste vedtægtsdato: 13.08.2015.
Kapital:
kr. 1,00.
Kapitalklasser: Nej
Indbetalingsmåde: Indbetalt kontant kr. 1,00 til kurs 100,00, fuldt indbetalt.
Stifter:
CVR-NR. 36993073 Bruun Kolbye Holding IVS, Virum Overdrevsvej 43, 2830 Virum, den 13.08.2015.
Direktion:
Thomas Bruun Kolbye, den 13.08.2015.
Selskabet tegnes af en direktør..
Første regnskabsår:
13.08.2015 - 31.12.2016.
Regnskabsår:
01.01 - 31.12.
Formål:
Selskabets formål er at leverer sundhedsydelser på tværs af landegrænser under reglerne iEU´s patientmobilitetsdirektiv, samt enhver i forbindelse hermed stående virksomhed.
1 registered in CVR.
P-number 1020652159Virum Overdrevsvej 43, 2830 Virum
